Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
Nicolas Boissel(Inserm), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Christine Terré(Hôpital André Mignot), Nathalie Contentin(Centre Henri Becquerel), Thierry de Revel(Hôpital d'instruction des Armées Percy), Cécile Pautas(Centre Hospitalier Universitaire Henri-Mondor), Claude Gardin(Sorbonne Université), Oumédaly Reman(University of Bern), N Philippe(Inserm), Aline Renneville(Université Paris-Sud), Bruno Quesnel(Université de Lille), Sandrine Geffroy(Inserm), Xavier Thomas(Hôpital Lyon Sud), Olivier Nibourel(Inserm), Dominique Bordessoule(Centre Hospitalier Universitaire de Limoges), Hervé Dombret(University of London Institute in Paris), Sylvie Castaigné(Hôpital André Mignot), Pascal Huchette(Centre Hospitalier d'Arras)
Cited by 218
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k